Navigation Links
Cardiac Science Increases R&D Capacity With 3-year Syncroness Agreement

BOTHELL, Wash., Feb. 4 /PRNewswire-FirstCall/ -- Cardiac Science (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, completed a three-year agreement for product design and engineering services from Colorado-based Syncroness, a leading design and engineering firm serving the medical devices industry.


"We expect considerable savings and speed-to-market improvements with Syncroness," said Bob Odell, vice president of engineering for Cardiac Science. The agreement increases Cardiac Science's engineering capacity to manage sustaining activities and new business opportunities. Odell adds, "This will allow seasoned Cardiac Science team members to focus on new customer solutions, revenue opportunities, and new advances in technology. As a result, we'll be even faster and more responsive to market needs."

"We've worked with Cardiac Science on a smaller scale and I can say they are a great partner," said chief marketing officer Jorg Lorscheider. "I'm confident we will reward Cardiac Science's trust with lowered costs, product development efficiencies, and an improved speed-to-market."

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit

About Syncroness

Syncroness (Westminster, CO) is a leading product design firm and a pioneer in the development of advanced business processes for engineering that increase profit and performance for the organizations we serve. For information, call 877.429.5005 or visit

Forward-Looking Statements

This press release contains forward-looking statements. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Forward-looking statements in this press release include, but are not limited to, those relating to Cardiac Science Corporation's expectations regarding cost savings or improved research and development capabilities and the resulting impact on operating results. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks are more fully described in Cardiac Science Corporation's Annual Report on Form 10-K for the year ended December 31, 2007 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2008. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.

     For more information,
     Company Contact:
     Mike Matysik
     Cardiac Science Corporation
     Senior Vice President and CFO

     Investor Contact:
     Doug Sherk
     Jenifer Kirtland
     EVC Group Inc.

     Media Contact:
     Christopher Gale
     EVC Group Inc.


SOURCE Cardiac Science
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The Sudden Cardiac Arrest Association Shoots Straight for the Heart
2. Experts Urge Limits on Use of Cardiac CT Scans
3. Proton pump inhibitors increase risk of heart attacks for patients on common cardiac drug
4. Easing regulations does not mean lower quality of cardiac care
5. New stretchable electrodes created to study stresses on cardiac cells
6. 2008 a Year of Growth and Unprecedented Service for The Larry King Cardiac Foundation
7. Cholesterol Levels May Not Measure Cardiac Risk
8. Newer Antipsychotics Pose Cardiac Risk: Study
9. Most heart attack patients cholesterol levels did not indicate cardiac risk
10. Penn study: Chances of surviving cardiac arrest depend on where patients are treated
11. Conference on cell therapy includes new session on stem cells for non-cardiac organ injury
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology: